Understand More About Next-Generation Sequencing at ELA 2012
News Apr 30, 2012
Select Biosciences has announced that Next-Generation Sequencing Automation will form one of the eight available conference streams.
A resounding success at ELA in 2011 and an ever growing area of interest in present day research Next-Generation Sequencing will take an important place in this year’s programme.
With participation from some of the industry’s leading experts in this field including Wilhelm Ansorge of ETH Lausanne and Vanessa Hayes of the J Craig Venter Institute, this stream aims to provide attendees with enhanced knowledge on the advances in next generation sequencing including sequencing platforms and 3rd generation sequencing technologies.
The ELA conference will run from 30th-31st May at the Congress Center Hamburg, Germany.
Registered delegates will have access to all eight conference streams and a topical exhibition, showcasing the latest developments in automated workflows and instruments.
Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone TumorsNews
The first genetic marker for the bone tumor, osteoblastoma, has been discovered. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment.READ MORE
Improved Method for Isolating Extracellular RNANews
In a breakthrough that could lead to powerful new ways to diagnose and track a wide range of medical conditions, scientists at The Rockefeller University have devised an improved method for isolating and identifying tiny fragments of RNA in human blood products.READ MORE